Tirzepatide vs Liraglutide Dosing Compared
Last updated: June 2026
Tirzepatide and liraglutide are both injectable incretin medicines that curb appetite, but they sit at opposite ends of the schedule: tirzepatide is injected once a week, while liraglutide is injected once every day. They also run on different milligram scales and different titration clocks, so a dose number from one tells you nothing about the other.
Have a tirzepatide vial and a target dose? Convert any weekly milligram dose to exact mL and U-100 syringe units in seconds.
Tirzepatide calculator →TL;DR — key takeaways
- Cadence is the headline difference. Tirzepatide is one injection per week; liraglutide is seven (one each day). That is 7 vs 1 sticks across a week.
- Different mg scales. Tirzepatide climbs 2.5 → 15 mg weekly; liraglutide for weight (Saxenda) climbs 0.6 → 3 mg daily. The numbers are not comparable across drugs.
- Different titration clocks. Liraglutide steps up about every week; tirzepatide holds each rung at least four weeks.
- Mechanism differs. Tirzepatide is a dual GIP/GLP-1 receptor agonist; liraglutide is a single GLP-1 receptor agonist.
- Units follow concentration, not the drug name. The same formula converts either dose to syringe units once you know the vial's mg/mL.
Two different molecules, two different clocks
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a short half-life of roughly 13 hours. That short window is exactly why it has to be taken every single day to keep a steady effect. Tirzepatide is a dual agonist — it activates both the GLP-1 receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor — and its half-life of about five days is what lets a single weekly injection hold a stable blood level.
Because the two drugs bind different receptor sets with different potencies, their effective milligram ranges do not line up. Liraglutide's top weight-management dose is 3 mg per day; tirzepatide's top dose is 15 mg per week. Neither the per-dose number nor any weekly total is interchangeable — comparing 3 mg of one against 15 mg of the other is meaningless arithmetic.
Side-by-side: dosing at a glance
| Property | Tirzepatide | Liraglutide |
|---|---|---|
| Class | GIP + GLP-1 dual agonist | GLP-1 receptor agonist |
| Injection frequency | Once weekly | Once daily |
| Approx. half-life | ~5 days | ~13 hours |
| Starting dose | 2.5 mg / week | 0.6 mg / day |
| Titration step interval | ≥ 4 weeks | ~1 week |
| Top weight dose | 15 mg / week | 3 mg / day |
| Titration ladder | 2.5, 5, 7.5, 10, 12.5, 15 | 0.6, 1.2, 1.8, 2.4, 3.0 |
| Route | Subcutaneous | Subcutaneous |
| Brand examples | Mounjaro, Zepbound | Victoza, Saxenda |
Figures reflect the FDA-approved Zepbound/Mounjaro and Saxenda/Victoza labels. Victoza (the type-2-diabetes version of liraglutide) tops out lower, at 1.8 mg per day. Compounded vials are drawn by hand, so you calculate the draw volume yourself; always follow your prescriber's protocol.
The two titration paths, visualised
Liraglutide steps up almost weekly across its first month, climbing the 0.6 mg ladder; tirzepatide holds each rung for a full four weeks. The diagram contrasts the injection cadence and the dose ramp of each.
How to turn any dose into syringe units
The milligram dose on a protocol is not what you read on the barrel — you read units, and a U-100 insulin syringe holds 100 units per 1 mL. The conversion is identical for either drug: find the concentration (mg/mL), divide your dose by it to get mL, then multiply by 100 to get units. Brand liraglutide ships as a pre-set 6 mg/mL pen, but compounded liraglutide and all tirzepatide vials are drawn by hand, so the maths matters.
Worked example 1 — tirzepatide weekly
Vial labelled 10 mg/mL, prescribed dose 5 mg once weekly.
5 mg ÷ 10 mg/mL = 0.5 mL. 0.5 mL × 100 units/mL = 50 units.
Draw 50 units once a week — half of a 1 mL syringe.
Worked example 2 — tirzepatide starting dose
Same 10 mg/mL vial, starting dose 2.5 mg weekly.
2.5 mg ÷ 10 mg/mL = 0.25 mL. 0.25 mL × 100 = 25 units.
Draw 25 units once a week.
Worked example 3 — liraglutide daily
Compounded vial at 6 mg/mL (the standard pen strength), dose 1.8 mg per day.
1.8 mg ÷ 6 mg/mL = 0.3 mL. 0.3 mL × 100 = 30 units.
Draw 30 units — every day, not once a week.
Worked example 4 — liraglutide top dose
Same 6 mg/mL vial, weight-management top dose 3.0 mg per day.
3.0 mg ÷ 6 mg/mL = 0.5 mL. 0.5 mL × 100 = 50 units.
Draw 50 units daily — the same 50 units as the weekly tirzepatide example, but seven times as often.
Worked example 5 — concentration changes the units
Liraglutide 1.8 mg from a stronger 10 mg/mL compounded vial: 1.8 ÷ 10 = 0.18 mL × 100 = 18 units.
Same dose, fewer units, because the vial is stronger. "How many units" has no answer without the mg/mL.
Dose-to-units reference chart
Common doses for each drug shown as units on a U-100 syringe at two concentrations. Confirm against your own vial label.
| Dose | At 6 mg/mL | At 10 mg/mL |
|---|---|---|
| 0.6 mg (lira start, daily) | 10 units | 6 units |
| 1.2 mg (lira, daily) | 20 units | 12 units |
| 1.8 mg (lira / Victoza max, daily) | 30 units | 18 units |
| 3.0 mg (Saxenda max, daily) | 50 units | 30 units |
| 2.5 mg (tirz start, weekly) | ~42 units | 25 units |
| 5 mg (tirz, weekly) | ~83 units | 50 units |
| 10 mg (tirz, weekly) | — (over 1 mL) | 100 units |
Note the empty cell: 10 mg from a 6 mg/mL vial needs 1.67 mL, more than a 1 mL syringe holds, so larger tirzepatide doses use a stronger vial. If a draw exceeds 1 mL, ask your pharmacy about a higher concentration.
How this is calculated
Every figure here rests on two facts: a U-100 syringe holds 100 units per mL, and concentration is dose divided by volume. There is no drug-specific constant — the arithmetic is the same for tirzepatide, liraglutide, or any other vialled peptide, which is why a single calculator handles both. The only thing that changes between these two drugs is how often you repeat the draw: once a week versus once a day. This is education and maths, not medical advice; the dose itself is set by your prescriber.
Frequently asked questions
Is tirzepatide just a stronger liraglutide?
No. Tirzepatide activates two receptors (GIP and GLP-1) while liraglutide activates one (GLP-1), and the two run on different milligram scales. A bigger number on the tirzepatide label does not mean a bigger dose of the same thing.
Why is one daily and the other weekly?
Half-life. Liraglutide clears in about 13 hours, so it needs a daily top-up; tirzepatide lasts around five days, so one weekly injection keeps a steady level.
Do I draw more units for liraglutide than tirzepatide?
It depends only on the vial concentration, not the drug. At 6 mg/mL, a 3 mg daily liraglutide dose is 50 units; at 10 mg/mL, a 5 mg weekly tirzepatide dose is also 50 units. The frequency is what differs.
Can I map my liraglutide dose onto tirzepatide?
No. Switching drugs means a fresh starting dose and titration plan set by your prescriber. The scales do not line up, so do not convert one dose into the other yourself.
Sources
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) (N Engl J Med 2022)
- Pi-Sunyer X, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity and Prediabetes) (N Engl J Med 2015)
- Frias JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2) (N Engl J Med 2021)
- ZEPBOUND (tirzepatide injection) Prescribing Information (DailyMed / FDA label)
- MOUNJARO (tirzepatide injection) Prescribing Information (DailyMed / FDA label)
- SAXENDA (liraglutide injection) Prescribing Information (DailyMed / FDA label)
- Farzam K, Patel P. Tirzepatide (StatPearls, NCBI Bookshelf)
- Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists (StatPearls, NCBI Bookshelf)
- Pharmacokinetics and Drug-Drug Interactions of Approved GLP-1 Receptor Agonists and a Dual GLP-1/GIP Receptor Agonist (PMC 2025)
This guide is for general educational purposes only and does not constitute medical advice. Always follow your prescriber’s specific instructions and consult a qualified clinician before changing any protocol.